What's in Carolina Eyecare Physicians, LLC's pipeline?

Carolina Eyecare Physicians, LLC has 7 drugs in our index: 7 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Carolina Eyecare Physicians, LLC's portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Pfizer, Bausch Health, Azienda USL Reggio Emilia - IRCCS, Allergan.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/carolina-eyecare-physicians-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Carolina Eyecare Physicians, LLC — Portfolio Competitive Intelligence Brief

Carolina Eyecare Physicians, LLC pipeline: 7 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

7 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Ilevro	Ilevro	marketed			Other
TriMoxiVanc	TriMoxiVanc	marketed
Gatifloxacin Ophthalmic	Gatifloxacin Ophthalmic	marketed	Quinolone Antimicrobial [EPC]
Prednisolone acetate 1% ophthalmic suspension	Prednisolone acetate 1% ophthalmic suspension	marketed	Corticosteroid	Glucocorticoid receptor	Ophthalmology
Moxifloxacin HCl 0.5%	Moxifloxacin HCl 0.5%	marketed	Fluoroquinolone antibiotic	Bacterial DNA gyrase and topoisomerase IV	Ophthalmology / Infectious Disease
Pred-Gati-Brom	Pred-Gati-Brom	marketed	Fixed-dose combination ophthalmic agent (corticosteroid + fluoroquinolone + bromide salt)		Ophthalmology
Bromfenac 0.075% Oph Solution	Bromfenac 0.075% Oph Solution	marketed	Nonsteroidal anti-inflammatory drug (NSAID)	Cyclooxygenase (COX-1 and COX-2)	Ophthalmology

Therapeutic area mix

Ophthalmology · 3
Ophthalmology / Infectious Disease · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 3 shared drug classes
Pfizer · 3 shared drug classes
Bausch Health · 2 shared drug classes
Azienda USL Reggio Emilia - IRCCS · 2 shared drug classes
Allergan · 2 shared drug classes
Bayer · 2 shared drug classes
· 2 shared drug classes
Bausch & Lomb Incorporated · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Carolina Eyecare Physicians, LLC:

Cite this brief

Drug Landscape (2026). Carolina Eyecare Physicians, LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/carolina-eyecare-physicians-llc. Accessed 2026-05-16.